$1M MRFF Grant Awarded to Fund Investigation of Cynata’s MSCs as a Treatment for Heart Disease

Cynata Therapeutics Limited announced that the Australian Government National Health and Medical Research Council has awarded a grant of approximately $1 million under the NHMRC 2021 MRFF Cardiovascular Health Mission, to fund a major preclinical research project to investigate Cynata’s Cymerus™ MSCs as a treatment for ischaemic heart disease.